Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA JUBILANT PHARMOVA GSK PHARMA/
JUBILANT PHARMOVA
 
P/E (TTM) x 62.7 -2,654.0 - View Chart
P/BV x 19.0 1.7 1,131.0% View Chart
Dividend Yield % 1.6 0.9 186.2%  

Financials

 GSK PHARMA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
JUBILANT PHARMOVA
Mar-23
GSK PHARMA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs1,684496 339.8%   
Low Rs1,231269 457.8%   
Sales per share (Unadj.) Rs191.9394.4 48.7%  
Earnings per share (Unadj.) Rs35.9-4.1 -880.5%  
Cash flow per share (Unadj.) Rs39.830.7 129.4%  
Dividends per share (Unadj.) Rs32.005.00 640.0%  
Avg Dividend yield %2.21.3 167.9%  
Book value per share (Unadj.) Rs102.9338.6 30.4%  
Shares outstanding (eoy) m169.41159.28 106.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.0 783.4%   
Avg P/E ratio x40.6-93.8 -43.3%  
P/CF ratio (eoy) x36.712.4 294.6%  
Price / Book Value ratio x14.21.1 1,254.8%  
Dividend payout %89.2-122.7 -72.7%   
Avg Mkt Cap Rs m246,85860,873 405.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5,95021,660 27.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51762,817 51.8%  
Other income Rs m1,007383 262.6%   
Total revenues Rs m33,52463,201 53.0%   
Gross profit Rs m8,0337,317 109.8%  
Depreciation Rs m6585,540 11.9%   
Interest Rs m181,882 1.0%   
Profit before tax Rs m8,364278 3,010.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288927 246.9%   
Profit after tax Rs m6,076-649 -936.5%  
Gross profit margin %24.711.6 212.1%  
Effective tax rate %27.4333.5 8.2%   
Net profit margin %18.7-1.0 -1,809.2%  
BALANCE SHEET DATA
Current assets Rs m24,94337,624 66.3%   
Current liabilities Rs m13,26417,724 74.8%   
Net working cap to sales %35.931.7 113.4%  
Current ratio x1.92.1 88.6%  
Inventory Days Days9725 396.7%  
Debtors Days Days21656 386.6%  
Net fixed assets Rs m6,98871,668 9.8%   
Share capital Rs m1,694159 1,064.8%   
"Free" reserves Rs m15,73553,772 29.3%   
Net worth Rs m17,43053,931 32.3%   
Long term debt Rs m031,104 0.0%   
Total assets Rs m31,930109,292 29.2%  
Interest coverage x462.61.1 40,308.7%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.00.6 177.2%   
Return on assets %19.11.1 1,691.6%  
Return on equity %34.9-1.2 -2,897.9%  
Return on capital %48.12.5 1,893.5%  
Exports to sales %00-   
Imports to sales %48.14.1 1,177.6%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,6302,564 609.6%   
Fx inflow Rs m1,6227,100 22.8%   
Fx outflow Rs m15,6302,564 609.6%   
Net fx Rs m-14,0084,536 -308.9%   
CASH FLOW
From Operations Rs m4,8426,607 73.3%  
From Investments Rs m8,079-5,444 -148.4%  
From Financial Activity Rs m-15,433-1,567 985.0%  
Net Cashflow Rs m-2,512301 -834.7%  

Share Holding

Indian Promoters % 0.0 47.4 -  
Foreign collaborators % 75.0 3.3 2,279.6%  
Indian inst/Mut Fund % 11.6 23.2 50.0%  
FIIs % 2.9 20.3 14.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 49.3 50.7%  
Shareholders   114,663 86,588 132.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Jubilant Pharmova Share Price Performance

Period GSK Pharma Jubilant Pharmova S&P BSE HEALTHCARE
1-Day 4.08% -0.31% 1.47%
1-Month -9.06% 2.44% -0.47%
1-Year 53.84% 109.77% 62.28%
3-Year CAGR 11.18% -6.72% 18.27%
5-Year CAGR 8.62% -2.73% 19.85%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.